Immunological effects of nivolumab immunotherapy in patients with oral cavity squamous cell carcinoma

Although checkpoint blockades have become widely used, the immunological impact in cancer patients, especially those with oral cavity squamous cell carcinoma (OCSCC), has not been well studied.

Source: BMC Cancer - March 17, 2020 Category: Cancer & Oncology Authors: Ying Xiong, David M. Neskey, Joshua D. Horton, Chrystal M. Paulos, Hannah M. Knochelmann, Kent E. Armeson and M. Rita I. Young Tags: Research article Source Type: research